HuGE Literature Finder
|
||
Records 1-29
|
Risk management decisions in women with BRCA1 and BRCA2 mutations.
American journal of surgery 2018 Feb . Morgan Rosemary, Brown Audrey, Hamman Kelly Jo, Sampson Jone, Naik Arpana, Massimino Krist |
|
Hereditary breast and ovarian cancer: new genes in confined pathways.
Nature reviews. Cancer 2016 Aug . Nielsen Finn Cilius, van Overeem Hansen Thomas, Sørensen Claus Storgaa |
|
Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
Annals of surgical oncology 2016 Jun . Murphy Brittany L, Hoskin Tanya L, Boughey Judy C, Degnim Amy C, Glazebrook Katrina N, Hieken Tina |
|
Dissimilarity between sporadic, non-BRCA1/2 families and hereditary breast cancer, linked to BRCA genes, in the Tunisian population.
Breast cancer (Tokyo, Japan) 2015 Oct . Riahi Aouatef, Gourabi Mohamel El, Chabouni-Bouhamed Habi |
|
Characterizing biased cancer-related cognitive processing: relationships with BRCA1/2 genetic mutation status, personal cancer history, age, and prophylactic surgery.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2014 Sep 33 (9): 1003-11. Carpenter Kristen M, Eisenberg Stacy, Weltfreid Sharone, Low Carissa A, Beran Tammy, Stanton Annette |
|
Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
Annals of surgical oncology 2013 Oct 20 (10): 3254-8. Greenup Rachel, Buchanan Adam, Lorizio Wendy, Rhoads Keelia, Chan Salina, Leedom Tracey, King Robin, McLennan Jane, Crawford Beth, Kelly Marcom P, Shelley Hwang |
|
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.
BMC cancer 2012 Oct 12 (1): 1. Bjørnslett M, Knappskog S, Lønning PE, Dørum A |
|
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jul 30 (21): 2654-63. Alsop Kathryn, Fereday Sian, Meldrum Cliff, deFazio Anna, Emmanuel Catherine, George Joshy, Dobrovic Alexander, Birrer Michael J, Webb Penelope M, Stewart Colin, Friedlander Michael, Fox Stephen, Bowtell David, Mitchell Gilli |
|
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Breast cancer research and treatment 2012 Apr 132 (2): 379-89. Joosse Simon A, Brandwijk Kim I M, Devilee Peter, Wesseling Jelle, Hogervorst Frans B L, Verhoef Senno, Nederlof Petra |
|
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.
Breast cancer research : BCR 2012 14 (6): R156. Rhiem Kerstin, Engel Christoph, Graeser Monika, Zachariae Silke, Kast Karin, Kiechle Marion, Ditsch Nina, Janni Wolfgang, Mundhenke Christoph, Golatta Michael, Varga Dominic, Preisler-Adams Sabine, Heinrich Tilman, Bick Ulrich, Gadzicki Dorothea, Briest Susanne, Meindl Alfons, Schmutzler Rita |
|
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Nov 19 (11): 2859-68. Engel Christoph, Versmold Beatrix, Wappenschmidt Barbara, Simard Jacques, Easton Douglas F, Peock Susan, Cook Margaret, Oliver Clare, Frost Debra, Mayes Rebecca, Evans D Gareth, Eeles Rosalind, Paterson Joan, Brewer Carole, , McGuffog Lesley, Antoniou Antonis C, Stoppa-Lyonnet Dominique, Sinilnikova Olga M, Barjhoux Laure, Frenay Marc, Michel Cécile, Leroux Dominique, Dreyfus Helene, Toulas Christine, Gladieff Laurence, Uhrhammer Nancy, Bignon Yves-Jean, Meindl Alfons, Arnold Norbert, Varon-Mateeva Raymonda, Niederacher Dieter, Preisler-Adams Sabine, Kast Karin, Deissler Helmut, Sutter Christian, Gadzicki Dorothea, Chenevix-Trench Georgia, Spurdle Amanda B, Chen Xiaoqing, Beesley Jonathan, , Olsson Håkan, Kristoffersson Ulf, Ehrencrona Hans, Liljegren Annelie, , van der Luijt Rob B, van Os Theo A, van Leeuwen Flora E, , Domchek Susan M, Rebbeck Timothy R, Nathanson Katherine L, Osorio Ana, Ramón y Cajal Teresa, Konstantopoulou Irene, Benítez Javier, Friedman Eitan, Kaufman Bella, Laitman Yael, Mai Phuong L, Greene Mark H, Nevanlinna Heli, Aittomäki Kristiina, Szabo Csilla I, Caldes Trinidad, Couch Fergus J, Andrulis Irene L, Godwin Andrew K, Hamann Ute, Schmutzler Rita K, |
|
Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Aug 28 (23): 3779-83. Passaperuma Kavitha, Warner Ellen, Hill Kimberley A, Gunasekara Anoma, Yaffe Martin |
|
Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.
Human mutation 2007 May 28 (5): 525-6. Ramus Susan J, Harrington Patricia A, Pye Carole, Peock Susan, Cook Margaret R, Cox Mark J, Jacobs Ian J, DiCioccio Richard A, Whittemore Alice S, Piver M Steven, EMBRACE , Easton Douglas F, Ponder Bruce A J, Pharoah Paul D P, Gayther Simon |
|
Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Social science & medicine (1982) 2004 Aug 59 (3): 553-65. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson |
|
Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.
Journal of behavioral medicine 2004 Aug 27 (4): 373-92. Halbert Chanita Hughes, Schwartz Marc D, Wenzel Lari, Narod Steven, Peshkin Beth N, Cella David, Lerman Car |
|
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 May 22 (10): 1823-9. Schwartz Marc D, Lerman Caryn, Brogan Barbara, Peshkin Beth N, Halbert Chanita Hughes, DeMarco Tiffani, Lawrence William, Main David, Finch Clinton, Magnant Colette, Pennanen Marie, Tsangaris Theodore, Willey Shawna, Isaacs Claudi |
|
Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
American journal of medical genetics. Part A 2004 Feb 124A (4): 346-55. van Roosmalen Mariëlle S, Stalmeier P F M, Verhoef L C G, Hoekstra-Weebers J E H M, Oosterwijk J C, Hoogerbrugge N, Moog U, van Daal W A |
|
Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.
British journal of cancer 2004 Jan 90 (2): 333-42. van Roosmalen M S, Stalmeier P F M, Verhoef L C G, Hoekstra-Weebers J E H M, Oosterwijk J C, Hoogerbrugge N, Moog U, van Daal W A |
|
Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Archives of surgery (Chicago, Ill. : 1960) 2003 Dec 138 (12): 1323-8; discussion 1329. Weitzel Jeffrey N, McCaffrey Sarah M, Nedelcu Raluca, MacDonald Deborah J, Blazer Kathleen R, Cullinane Carey |
|
Sociocultural influences on participation in genetic risk assessment and testing among African American women.
Patient education and counseling 2003 Oct 51 (2): 107-14. Hughes Chanita, Fasaye Grace Ann, LaSalle V Holland, Finch Clint |
|
Psychological impact of genetic testing in women from high-risk breast cancer families.
European journal of cancer (Oxford, England : 1990) 2002 Oct 38 (15): 2025-31. Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M, Brown J, Tucker |
|
Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Oct 11 (10 Pt 1): 1115-8. Peshkin Beth N, Schwartz Marc D, Isaacs Claudine, Hughes Chanita, Main David, Lerman Car |
|
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Breast cancer research and treatment 2002 May 73 (2): 97-112. Lodder Litanja N, Frets Petra G, Trijsburg R Willem, Meijers-Heijboer E Johanna, Klijn Jan G M, Seynaeve Caroline, van Geel Albertus N, Tilanus Madeleine M A, Bartels Carina C M, Verhoog Leon C, Brekelmans Cecile T M, Burger Curt W, Niermeijer Martinus |
|
Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.
Cancer 2001 Aug 92 (4): 932-40. Schwartz M D, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson |
|
Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer.
American journal of surgery 2001 May 181 (5): 431-3. Morris KT, Johnson N, Krasikov N, Allen M, Dorsey P |
|
Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2001 10 (7): 595-607. Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson |
|
An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.
Journal of medical genetics 2000 Nov 37 (11): 866-74. Metcalfe K A, Liede A, Hoodfar E, Scott A, Foulkes W D, Narod S |
|
Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Psycho-oncology 0 12 (5): 410-27. Bluman Leslie G, Rimer Barbara K, Regan Sterba Katherine, Lancaster Julia, Clark Shelly, Borstelmann Nancy, Iglehart J Dirk, Winer Eric |
|
Early adoption of BRCA1/2 testing: who and why.
Genetics in medicine : official journal of the American College of Medical Genetics 0 5 (2): 92-8. Armstrong Katrina, Weiner Janet, Weber Barbara, Asch David |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: